Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 03 June, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Gillanders Arbuthnot & Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 3, 2025, 2:50 am

Market Cap 281 Cr.
Current Price 132
High / Low 138/75.0
Stock P/E17.7
Book Value 115
Dividend Yield0.00 %
ROCE6.94 %
ROE6.87 %
Face Value 10.0
PEG Ratio0.21

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Gillanders Arbuthnot & Company Ltd

Competitors of Gillanders Arbuthnot & Company Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Goodricke Group Ltd 435 Cr. 201 357/15929.5 1250.00 %5.29 %5.76 % 10.0
Diana Tea Company Ltd 46.1 Cr. 30.8 53.8/23.5 43.00.00 %1.22 %6.88 % 5.00
Bengal Tea & Fabrics Ltd 135 Cr. 150 227/115 2130.67 %5.42 %1.11 % 10.0
Bansisons Tea Industries Ltd 3.54 Cr. 5.60 8.90/3.80 9.270.00 %0.50 %1.02 % 10.0
B&A Ltd 146 Cr. 470 695/44017.7 4550.00 %8.97 %6.04 % 10.0
Industry Average9,216.50 Cr409.3847.18244.050.32%7.72%13.73%7.00

All Competitor Stocks of Gillanders Arbuthnot & Company Ltd

Quarterly Result

MetricMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
Sales 91.77124.81143.56103.2477.4287.68105.42101.4368.7584.85126.75127.64103.94
Expenses 98.72121.76119.46101.8294.0490.3096.42125.7684.4190.11101.46119.87106.03
Operating Profit -6.953.0524.101.42-16.62-2.629.00-24.33-15.66-5.2625.297.77-2.09
OPM % -7.57%2.44%16.79%1.38%-21.47%-2.99%8.54%-23.99%-22.78%-6.20%19.95%6.09%-2.01%
Other Income 2.3412.603.916.077.674.591.868.25-1.071.743.5313.233.99
Interest 4.875.244.393.994.423.983.513.942.863.462.852.953.10
Depreciation 2.972.953.093.012.913.033.152.862.722.672.782.802.61
Profit before tax -12.457.4620.530.49-16.28-5.044.20-22.88-22.31-9.6523.1915.25-3.81
Tax % -56.87%8.58%11.89%-51.02%-33.54%4.37%13.33%-2.32%10.49%1.76%7.37%14.56%-153.54%
Net Profit -5.376.8118.090.74-10.81-5.263.64-22.35-24.65-9.8221.4713.032.04
EPS in Rs -2.523.198.480.35-5.07-2.461.71-10.47-11.55-4.6010.066.110.96

Last Updated: May 31, 2025, 9:11 am

Below is a detailed analysis of the quarterly data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Sales, as of Mar 2025, the value is 103.94 Cr.. The value appears to be declining and may need further review. It has decreased from 127.64 Cr. (Dec 2024) to 103.94 Cr., marking a decrease of 23.70 Cr..
  • For Expenses, as of Mar 2025, the value is 106.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 119.87 Cr. (Dec 2024) to 106.03 Cr., marking a decrease of 13.84 Cr..
  • For Operating Profit, as of Mar 2025, the value is -2.09 Cr.. The value appears to be declining and may need further review. It has decreased from 7.77 Cr. (Dec 2024) to -2.09 Cr., marking a decrease of 9.86 Cr..
  • For OPM %, as of Mar 2025, the value is -2.01%. The value appears to be declining and may need further review. It has decreased from 6.09% (Dec 2024) to -2.01%, marking a decrease of 8.10%.
  • For Other Income, as of Mar 2025, the value is 3.99 Cr.. The value appears to be declining and may need further review. It has decreased from 13.23 Cr. (Dec 2024) to 3.99 Cr., marking a decrease of 9.24 Cr..
  • For Interest, as of Mar 2025, the value is 3.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.95 Cr. (Dec 2024) to 3.10 Cr., marking an increase of 0.15 Cr..
  • For Depreciation, as of Mar 2025, the value is 2.61 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.80 Cr. (Dec 2024) to 2.61 Cr., marking a decrease of 0.19 Cr..
  • For Profit before tax, as of Mar 2025, the value is -3.81 Cr.. The value appears to be declining and may need further review. It has decreased from 15.25 Cr. (Dec 2024) to -3.81 Cr., marking a decrease of 19.06 Cr..
  • For Tax %, as of Mar 2025, the value is -153.54%. The value appears to be improving (decreasing) as expected. It has decreased from 14.56% (Dec 2024) to -153.54%, marking a decrease of 168.10%.
  • For Net Profit, as of Mar 2025, the value is 2.04 Cr.. The value appears to be declining and may need further review. It has decreased from 13.03 Cr. (Dec 2024) to 2.04 Cr., marking a decrease of 10.99 Cr..
  • For EPS in Rs, as of Mar 2025, the value is 0.96. The value appears to be declining and may need further review. It has decreased from 6.11 (Dec 2024) to 0.96, marking a decrease of 5.15.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:38 am

MetricMar 2007Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 355863817681665751660431406449363443
Expenses 333821812653615686632400377437397417
Operating Profit 2242528506528313012-3426
OPM % 6%5%1%4%7%9%4%7%7%3%-9%6%
Other Income 1191230211226717301422
Interest 104251545050483723181412
Depreciation 92119222420201612121211
Profit before tax 14-12-53-18-47-12-151112-4625
Tax % 21%-27%4%4%112%95%22%2%-42%-22%6%-7%
Net Profit 11-9-55-19-90-15-161615-4927
EPS in Rs 6.69-4.16-25.93-8.83-4.020.15-7.13-7.327.666.94-22.7812.52
Dividend Payout % 25%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-511.11%65.45%52.63%100.00%-6.67%200.00%-6.25%-426.67%155.10%
Change in YoY Net Profit Growth (%)0.00%576.57%-12.82%47.37%-106.67%206.67%-206.25%-420.42%581.77%

Gillanders Arbuthnot & Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:-6%
5 Years:-8%
3 Years:3%
TTM:22%
Compounded Profit Growth
10 Years:14%
5 Years:21%
3 Years:1%
TTM:133%
Stock Price CAGR
10 Years:10%
5 Years:40%
3 Years:27%
1 Year:56%
Return on Equity
10 Years:-6%
5 Years:-2%
3 Years:-4%
Last Year:7%

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:30 pm

MonthMar 2007Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 112121212121212121212121
Reserves 107266155262271268255231248255196224
Borrowings 91456480449424392366227183145129139
Other Liabilities 72242209203225244214145144129130130
Total Liabilities 281985865936942925857624597550477514
Fixed Assets 112421310441432427421315312298263256
CWIP 101149171415141211913
Investments 1328282934291783000
Other Assets 145525522457460454404287271241205245
Total Assets 281985865936942925857624597550477514

Below is a detailed analysis of the balance sheet data for Gillanders Arbuthnot & Company Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 21.00 Cr..
  • For Reserves, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 196.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 28.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 139.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 129.00 Cr. (Mar 2024) to 139.00 Cr., marking an increase of 10.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 130.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 130.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 514.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 256.00 Cr.. The value appears to be declining and may need further review. It has decreased from 263.00 Cr. (Mar 2024) to 256.00 Cr., marking a decrease of 7.00 Cr..
  • For CWIP, as of Mar 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 4.00 Cr..
  • For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 245.00 Cr.. The value appears strong and on an upward trend. It has increased from 205.00 Cr. (Mar 2024) to 245.00 Cr., marking an increase of 40.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 514.00 Cr.. The value appears strong and on an upward trend. It has increased from 477.00 Cr. (Mar 2024) to 514.00 Cr., marking an increase of 37.00 Cr..

Notably, the Reserves (224.00 Cr.) exceed the Borrowings (139.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2007Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +423840476910273686948338
Cash from Investing Activity +-31-44-841-14-181108-211-3-7
Cash from Financing Activity +-1218-30-83-74-82-73-178-68-57-30-3
Net Cash Flow-11335-2011-2-12-0-2

Free Cash Flow

MonthMar 2007Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-69.00-414.00-475.00-421.00-374.00-327.00-338.00-196.00-153.00-133.00-163.00-113.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2006Mar 2007Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days292656575453474554362129
Inventory Days116130135156207253219206240389287314
Days Payable999792112148180166164163220129164
Cash Conversion Cycle47599910111312610087130204179180
Working Capital Days64728899107907152821058564
ROCE %10%-0%1%6%8%4%4%7%4%-8%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters69.08%69.08%69.08%69.08%69.08%69.08%69.08%69.08%69.08%69.08%69.08%69.08%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.10%0.00%0.00%
DIIs2.96%1.69%1.36%1.33%0.82%0.64%0.32%0.31%0.31%0.31%0.31%0.31%
Government0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%
Public27.93%29.19%29.53%29.56%30.07%30.25%30.55%30.57%30.57%30.47%30.57%30.58%
No. of Shareholders9,7388,8478,8318,7919,1509,5539,5769,52810,51110,24010,19710,046

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) -22.786.957.66-7.32-7.13
Diluted EPS (Rs.) -22.786.957.66-7.32-7.13
Cash EPS (Rs.) -17.2712.5513.490.192.08
Book Value[Excl.RevalReserv]/Share (Rs.) 101.89129.69126.44118.37129.29
Book Value[Incl.RevalReserv]/Share (Rs.) 101.89129.69126.44118.37129.29
Revenue From Operations / Share (Rs.) 170.22210.39190.42201.83309.26
PBDIT / Share (Rs.) -9.3614.7822.1218.7021.23
PBIT / Share (Rs.) -14.879.1816.2911.1912.02
PBT / Share (Rs.) -21.565.715.38-7.15-5.85
Net Profit / Share (Rs.) -22.786.957.66-7.32-7.13
NP After MI And SOA / Share (Rs.) -22.786.957.66-7.32-7.13
PBDIT Margin (%) -5.507.0211.619.266.86
PBIT Margin (%) -8.734.368.555.543.88
PBT Margin (%) -12.662.712.82-3.54-1.89
Net Profit Margin (%) -13.383.304.02-3.62-2.30
NP After MI And SOA Margin (%) -13.383.304.02-3.62-2.30
Return on Networth / Equity (%) -22.355.356.05-6.18-5.51
Return on Capital Employeed (%) -12.436.069.996.966.28
Return On Assets (%) -10.192.692.73-2.50-1.77
Long Term Debt / Equity (X) 0.080.090.210.300.40
Total Debt / Equity (X) 0.530.470.630.731.06
Asset Turnover Ratio (%) 0.700.780.640.560.74
Current Ratio (X) 0.851.011.030.990.87
Quick Ratio (X) 0.360.470.500.610.50
Inventory Turnover Ratio (X) 0.520.780.950.571.13
Interest Coverage Ratio (X) -1.401.752.031.080.94
Interest Coverage Ratio (Post Tax) (X) -2.411.231.700.630.48
Enterprise Value (Cr.) 282.86273.58318.10271.78307.23
EV / Net Operating Revenue (X) 0.770.600.780.630.46
EV / EBITDA (X) -14.158.676.746.816.78
MarketCap / Net Operating Revenue (X) 0.430.290.340.210.06
Price / BV (X) 0.710.470.510.360.14
Price / Net Operating Revenue (X) 0.430.290.340.210.06
EarningsYield -0.310.110.11-0.16-0.37

After reviewing the key financial ratios for Gillanders Arbuthnot & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 5. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
  • For Diluted EPS (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 5. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
  • For Cash EPS (Rs.), as of Mar 24, the value is -17.27. This value is below the healthy minimum of 3. It has decreased from 12.55 (Mar 23) to -17.27, marking a decrease of 29.82.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.89. It has decreased from 129.69 (Mar 23) to 101.89, marking a decrease of 27.80.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 101.89. It has decreased from 129.69 (Mar 23) to 101.89, marking a decrease of 27.80.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 170.22. It has decreased from 210.39 (Mar 23) to 170.22, marking a decrease of 40.17.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is -9.36. This value is below the healthy minimum of 2. It has decreased from 14.78 (Mar 23) to -9.36, marking a decrease of 24.14.
  • For PBIT / Share (Rs.), as of Mar 24, the value is -14.87. This value is below the healthy minimum of 0. It has decreased from 9.18 (Mar 23) to -14.87, marking a decrease of 24.05.
  • For PBT / Share (Rs.), as of Mar 24, the value is -21.56. This value is below the healthy minimum of 0. It has decreased from 5.71 (Mar 23) to -21.56, marking a decrease of 27.27.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 2. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is -22.78. This value is below the healthy minimum of 2. It has decreased from 6.95 (Mar 23) to -22.78, marking a decrease of 29.73.
  • For PBDIT Margin (%), as of Mar 24, the value is -5.50. This value is below the healthy minimum of 10. It has decreased from 7.02 (Mar 23) to -5.50, marking a decrease of 12.52.
  • For PBIT Margin (%), as of Mar 24, the value is -8.73. This value is below the healthy minimum of 10. It has decreased from 4.36 (Mar 23) to -8.73, marking a decrease of 13.09.
  • For PBT Margin (%), as of Mar 24, the value is -12.66. This value is below the healthy minimum of 10. It has decreased from 2.71 (Mar 23) to -12.66, marking a decrease of 15.37.
  • For Net Profit Margin (%), as of Mar 24, the value is -13.38. This value is below the healthy minimum of 5. It has decreased from 3.30 (Mar 23) to -13.38, marking a decrease of 16.68.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is -13.38. This value is below the healthy minimum of 8. It has decreased from 3.30 (Mar 23) to -13.38, marking a decrease of 16.68.
  • For Return on Networth / Equity (%), as of Mar 24, the value is -22.35. This value is below the healthy minimum of 15. It has decreased from 5.35 (Mar 23) to -22.35, marking a decrease of 27.70.
  • For Return on Capital Employeed (%), as of Mar 24, the value is -12.43. This value is below the healthy minimum of 10. It has decreased from 6.06 (Mar 23) to -12.43, marking a decrease of 18.49.
  • For Return On Assets (%), as of Mar 24, the value is -10.19. This value is below the healthy minimum of 5. It has decreased from 2.69 (Mar 23) to -10.19, marking a decrease of 12.88.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 23) to 0.08, marking a decrease of 0.01.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.53. This value is within the healthy range. It has increased from 0.47 (Mar 23) to 0.53, marking an increase of 0.06.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.70. It has decreased from 0.78 (Mar 23) to 0.70, marking a decrease of 0.08.
  • For Current Ratio (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1.5. It has decreased from 1.01 (Mar 23) to 0.85, marking a decrease of 0.16.
  • For Quick Ratio (X), as of Mar 24, the value is 0.36. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 23) to 0.36, marking a decrease of 0.11.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.52. This value is below the healthy minimum of 4. It has decreased from 0.78 (Mar 23) to 0.52, marking a decrease of 0.26.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is -1.40. This value is below the healthy minimum of 3. It has decreased from 1.75 (Mar 23) to -1.40, marking a decrease of 3.15.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.41. This value is below the healthy minimum of 3. It has decreased from 1.23 (Mar 23) to -2.41, marking a decrease of 3.64.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 282.86. It has increased from 273.58 (Mar 23) to 282.86, marking an increase of 9.28.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 23) to 0.77, marking an increase of 0.17.
  • For EV / EBITDA (X), as of Mar 24, the value is -14.15. This value is below the healthy minimum of 5. It has decreased from 8.67 (Mar 23) to -14.15, marking a decrease of 22.82.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.43, marking an increase of 0.14.
  • For Price / BV (X), as of Mar 24, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.71, marking an increase of 0.24.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.43. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 23) to 0.43, marking an increase of 0.14.
  • For EarningsYield, as of Mar 24, the value is -0.31. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 23) to -0.31, marking a decrease of 0.42.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Gillanders Arbuthnot & Company Ltd as of June 3, 2025 is: 114.11

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 3, 2025, Gillanders Arbuthnot & Company Ltd is Overvalued by 13.55% compared to the current share price 132.00

Intrinsic Value of Gillanders Arbuthnot & Company Ltd as of June 3, 2025 is: 209.46

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 3, 2025, Gillanders Arbuthnot & Company Ltd is Undervalued by 58.68% compared to the current share price 132.00

Last 5 Year EPS CAGR: 83.56%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
    1. The stock has a low average ROCE of 3.00%, which may not be favorable.
    2. The stock has a high average Working Capital Days of 81.58, which may not be favorable.
    3. The stock has a high average Cash Conversion Cycle of 118.75, which may not be favorable.
    4. The company has higher borrowings (290.08) compared to reserves (228.17), which may suggest financial risk.
    5. The company has not shown consistent growth in sales (573.67) and profit (-7.58).

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillanders Arbuthnot & Company Ltd:
      1. Net Profit Margin: -13.38%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: -12.43% (Industry Average ROCE: 7.72%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: -22.35% (Industry Average ROE: 13.73%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): -2.41
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 0.36
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 17.7 (Industry average Stock P/E: 47.18)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0.53
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Gillanders Arbuthnot & Company Ltd. is a Public Limited Listed company incorporated on 01/02/1935 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L51909WB1935PLC008194 and registration number is 008194. Currently Company is involved in the business activities of Growing of tea. Company's Total Operating Revenue is Rs. 412.75 Cr. and Equity Capital is Rs. 21.34 Cr. for the Year ended 31/03/2025.
    INDUSTRYADDRESSCONTACT
    Plantations - Tea & CoffeeC-4, Gillander House, Netaji Subhas Road Kolkata West Bengal 700001gillander@gillandersarbuthnot.com
    http://www.gillandersarbuthnot.com
    Management
    NamePosition Held
    Mr. Arun Kumar KothariChairman
    Mr. Mahesh SodhaniManaging Director & CEO
    Mrs. Prabhawati Devi KothariNon Executive Director
    Mr. N PachisiaIndependent Director
    Mr. Arvind BahetiIndependent Director
    Mr. Charudatta Raghvendra PrayagIndependent Director
    Mr. Kothaneth AshokIndependent Director

    FAQ

    What is the intrinsic value of Gillanders Arbuthnot & Company Ltd?

    Gillanders Arbuthnot & Company Ltd's intrinsic value (as of 02 June 2025) is ₹114.11 — 13.55% lower the current market price of 132.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 281 Cr. market cap, FY2025-2026 high/low of ₹138/75.0, reserves of 224 Cr, and liabilities of 514 Cr.

    What is the Market Cap of Gillanders Arbuthnot & Company Ltd?

    The Market Cap of Gillanders Arbuthnot & Company Ltd is 281 Cr..

    What is the current Stock Price of Gillanders Arbuthnot & Company Ltd as on 02 June 2025?

    The current stock price of Gillanders Arbuthnot & Company Ltd as on 02 June 2025 is 132.

    What is the High / Low of Gillanders Arbuthnot & Company Ltd stocks in FY 2025-2026?

    In FY 2025-2026, the High / Low of Gillanders Arbuthnot & Company Ltd stocks is ₹138/75.0.

    What is the Stock P/E of Gillanders Arbuthnot & Company Ltd?

    The Stock P/E of Gillanders Arbuthnot & Company Ltd is 17.7.

    What is the Book Value of Gillanders Arbuthnot & Company Ltd?

    The Book Value of Gillanders Arbuthnot & Company Ltd is 115.

    What is the Dividend Yield of Gillanders Arbuthnot & Company Ltd?

    The Dividend Yield of Gillanders Arbuthnot & Company Ltd is 0.00 %.

    What is the ROCE of Gillanders Arbuthnot & Company Ltd?

    The ROCE of Gillanders Arbuthnot & Company Ltd is 6.94 %.

    What is the ROE of Gillanders Arbuthnot & Company Ltd?

    The ROE of Gillanders Arbuthnot & Company Ltd is 6.87 %.

    What is the Face Value of Gillanders Arbuthnot & Company Ltd?

    The Face Value of Gillanders Arbuthnot & Company Ltd is 10.0.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Gillanders Arbuthnot & Company Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE